🔺 What to do when markets are at an all-time high? Find smart bargains, like these.See Undervalued Stocks

Valiant Laboratories' IPO debuts with a premium, funding Gujarat-based chemicals facility

EditorAmbhini Aishwarya
Published 10/06/2023, 02:56 AM
© Reuters.
VALO
-
VALO
-

Valiant Laboratories, a company specializing in paracetamol production, has made a successful debut on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) today, with its initial public offering (IPO) managed by Unistone Capital Pvt. The IPO has been oversubscribed, drawing substantial interest from various investors.

The proceeds from this IPO will be directed towards funding a specialty chemicals facility in Gujarat. This facility is under the banner of Valiant Advanced Sciences Pvt., and is expected to have an annual capacity of 9,000 metric tons.

The investment in this facility comes at a time when the paracetamol active pharmaceutical ingredient (API) industry is witnessing growth. The industry is projected to expand at a compound annual growth rate (CAGR) of 5-7% between fiscal 2023 and fiscal 2027. This growth is largely driven by domestic formulation manufacturers and export markets.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.